论文部分内容阅读
2011年中国维生素产量稳中有增,预计全年维生素产量达24万t,市场价值28亿美元。出口维生素预计21万t(未包括氯化胆碱,氯化胆碱出口量12.5万t),出口量同比增长7%。近两年,中国出口维生素量增长迅猛。从出口区域结构来看,北美份额逐渐下降,欧洲份额逐渐增长。而出口增速也表明,欧洲是中国维生素近两年出口量猛增的引擎。部分品种从之前的竞争格局迅速转变为供应方格局,转变之快让人措手不及;也有品种(如:烟酰胺、维生素D3)从之前的垄断格局向着激烈竞争发展;还有部分品种(如:维生素B12、泛酸钙、维生素C)仍然挣扎在激烈竞争的环境中等待变局。
China’s vitamin output in 2011 steadily increased, the annual vitamin output is expected to 240,000 t, the market value of 2.8 billion. Export vitamin is expected to 210,000 t (not including choline chloride, choline chloride exports 125,000 t), exports increased by 7%. In the past two years, the volume of vitamin exports in China has been growing rapidly. From the perspective of the export zone structure, the share of North America gradually declines and the share of Europe gradually increases. The export growth rate also shows that Europe is China’s vitamin export volume soared in recent years, the engine. Some varieties rapidly changed from the previous competition pattern to the pattern of supply-siders. The rapid change brought people unprepared. Some varieties (such as nicotinamide and vitamin D3) developed from the previous monopoly to fierce competition. Some varieties (such as vitamins B12, calcium pantothenate, vitamin C) are still struggling in a highly competitive environment waiting for a change.